Stock-Based Compensation for Abbott Laboratories (ABT)
Stock-Based Compensation for Abbott Laboratories (ABT): headline value $664.00M · YoY -1.3%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingStock-Based CompensationSwitch metric
Latest period
$664.00M
YoY change
-1.3%
5Y CAGR
+4.0%
Peak year (2022)
$685.00M
Latest annual
$664.00M
Stock-Based Compensation history chart for Abbott Laboratories (ABT) from 1989 to 2025
Stock-Based Compensation history table for Abbott Laboratories (ABT) from 1989 to 2025
| Fiscal year | Period ended | Reported | Stock-Based Compensation | YoY |
|---|---|---|---|---|
| 2025 | $664.00M | -1.3% | ||
| 2024 | $673.00M | +4.5% | ||
| 2023 | $644.00M | -6.0% | ||
| 2022 | $685.00M | +7.0% | ||
| 2021 | $640.00M | +17.2% | ||
| 2020 | $546.00M | +5.2% | ||
| 2019 | $519.00M | +8.8% | ||
| 2018 | $477.00M | +17.5% | ||
| 2017 | $406.00M | +31.0% | ||
| 2016 | $310.00M | +6.2% | ||
| 2015 | $292.00M | +18.7% | ||
| 2014 | $246.00M | -6.1% | ||
| 2013 | $262.00M | -39.5% | ||
| 2012 | $433.00M | +13.1% | ||
| 2011 | $383.00M | -1.1% | ||
| 2010 | $387.18M | +5.7% | ||
| 2009 | $366.36M | +5.6% | ||
| 2008 | $347.01M | +649.0% | ||
| 2007 | $46.33M | -66.1% | ||
| 2006 | $136.47M | +1300.5% | ||
| 2005 | $9.74M | -4.6% | ||
| 2004 | $10.22M | +33.5% | ||
| 2003 | $7.66M | -34.7% | ||
| 2002 | $11.72M | — | ||
| 2001 | $0 | — | ||
| 2000 | $0 | — | ||
| 1999 | $0 | — | ||
| 1998 | $0 | — | ||
| 1997 | $0 | — | ||
| 1996 | $0 | — | ||
| 1995 | $0 | — | ||
| 1994 | $0 | — | ||
| 1993 | $0 | — | ||
| 1992 | $0 | — | ||
| 1991 | $0 | — | ||
| 1990 | $0 | — | ||
| 1989 | $0 | — |
Stock-Based Compensation values are taken from Abbott Laboratories's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Abbott Laboratories (ABT) stock-based compensation totalled $664.00M – edged down 1.3% year-over-year.
Through 2020–2025 (5 years), Abbott Laboratories stock-based compensation delivered a +4.0% annualised rate; with the latest reading among the more recent periods of the dataset.
2022 marks the peak stock-based compensation at $685.00M, with the historical low of $0 recorded in 1989.
Abbott Laboratories (ABT) sits 4th of 8 Healthcare peers we track on this metric, against a peer median of $313.00M.
Abbott Laboratories Stock-Based Compensation by Year
Abbott Laboratories Stock-Based Compensation 2025: $664.00M
Abbott Laboratories stock-based compensation in 2025 was $664.00M, edged down 1.3% below 2024.
Abbott Laboratories Stock-Based Compensation 2024: $673.00M
Abbott Laboratories stock-based compensation in 2024 was $673.00M, edged up 4.5% from 2023.
Abbott Laboratories Stock-Based Compensation 2023: $644.00M
Abbott Laboratories stock-based compensation in 2023 was $644.00M, declined 6.0% below 2022.
Abbott Laboratories Stock-Based Compensation 2022: $685.00M
Abbott Laboratories stock-based compensation in 2022 was $685.00M, grew 7.0% from 2021. This figure represents the highest annual value in the available history.
Abbott Laboratories Stock-Based Compensation 2021: $640.00M
Abbott Laboratories stock-based compensation in 2021 was $640.00M.
See more financial history for Abbott Laboratories (ABT).
Sector peers — Stock-Based Compensation
Companies in the same sector as Abbott Laboratories, ranked by their latest stock-based compensation.
| Company | Stock-Based Compensation | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $1.35B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $971.00M | Healthcare |
| AbbVie Inc. (ABBV) | $955.00M | Healthcare |
| Eli Lilly and Company (LLY) | $626.00M | Healthcare |
| AstraZeneca PLC (AZN) | $0 | Healthcare |
| Merck & Co., Inc. (MRK) | $0 | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
| Novo Nordisk A/S (NVO) | $0 | Healthcare |
Frequently asked questions
What is Abbott Laboratories's stock-based compensation?
Latest reported stock-based compensation for Abbott Laboratories (ABT) is $664.00M (period ending December 31, 2025).
How has Abbott Laboratories stock-based compensation changed year-over-year?
Abbott Laboratories (ABT) stock-based compensation changed -1.3% year-over-year on the latest annual filing.
What is the long-term growth rate of Abbott Laboratories stock-based compensation?
Abbott Laboratories (ABT) stock-based compensation compound annual growth rate is +4.0% over the most recent 5 years available.
When did Abbott Laboratories stock-based compensation hit its highest annual value?
Abbott Laboratories stock-based compensation reached its highest annual value of $685.00M in 2022.
What was Abbott Laboratories stock-based compensation in 2024?
Abbott Laboratories (ABT) stock-based compensation in 2024 was $673.00M.
What was Abbott Laboratories stock-based compensation in 2025?
Abbott Laboratories (ABT) stock-based compensation in 2025 was $664.00M.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
ABT Overview
Company profile, financial tools, and key metrics
ABT Revenue Counter
Earns $1,431 every second. See per minute, hour, and day.
ABT Earnings Counter
Earns $199.01 per second net profit. See per minute, hour, and day.
ABT Economic Scale
Exceeds Paraguay's GDP. Compare with world economies.
ABT What If Invested
What if you had invested $1,000? See historical returns from any date.
ABT How It Makes Money
Discover visual breakdown of $45.13B in revenue — where it comes from and where it goes.
ABT Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ABT Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ABT Daily Price Character
Steady · 48.2% historical win rate (green days). Streaks & record days.
ABT Buybacks
0.41% TTM buyback yield. Shareholder yield & SBC comparison.
ABT Stock Split History
9 splits on record. Dates, ratios, and cumulative multiple.
ABT Dividend Profile
Yield: 2.67%. Safety: 6/8. See full history.
ABT Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
ABT Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.